Streamline your analytics ordering and sample coordination with the KBI Biopharma Analytical Portal. Say goodbye to the back-and-forth emails and enjoy seamless access to quotes, sample submissions, and project tracking—all in one convenient platform. Our user-friendly portal connects you directly with subject matter experts, providing the information you need quickly to keep your projects moving efficiently. Learn how our Analytics Portal can enhance your workflow: https://hubs.ly/Q02Xx8K-0 #KBIBiopharma #CDMO #AnalyticalServices
KBI Biopharma’s Post
More Relevant Posts
-
Overcome the hurdles of outsourced testing with KBI Biopharma’s Analytics Portal! We’re here to eliminate delays, set a new standard of seamless communication, and ensure effortless access to your results so you can focus on what matters: reaching your milestones on time!
Streamline your analytics ordering and sample coordination with the KBI Biopharma Analytical Portal. Say goodbye to the back-and-forth emails and enjoy seamless access to quotes, sample submissions, and project tracking—all in one convenient platform. Our user-friendly portal connects you directly with subject matter experts, providing the information you need quickly to keep your projects moving efficiently. Learn how our Analytics Portal can enhance your workflow: https://hubs.ly/Q02Xx8K-0 #KBIBiopharma #CDMO #AnalyticalServices
To view or add a comment, sign in
-
I am so excited to announce the publication of our latest Biopharma R&D Productivity report from Colin Terry and Kevin Dondarski . The good news is that biopharma R&D productivity is trending upward - now at 4.1% IRR - from an all-time low of 1.2% last year. Other insights include: • R&D cost per asset remained flat while peak sales per asset declined. The overall number of late stage assets increased however (less late-stage failures), which is driving the rise in IRR • Despite significant headwinds in terms of increasing trial complexity, concentrated therapeutic area focus, and a changing regulatory environment (e.g. Inflation Reduction Act), the report highlights exciting opportunities to utilize technology – namely AI – to bend the curve of R&D productivity Please read their insightful analysis and share with your R&D colleagues! Nick Lingler Amy Cheung Kevin Sullivan Amanda Kirby Bowles Siddharth Karia Nirav Mehta Raveen Sharma Jeffrey Morgan Ernest Horany Parag Limaye Ming Shen Aditya Kudumala Melanie Stephenson Rob Brathwaite George Pushchinsky Seth Levine Dawn Anderson Mukesh Singhal Daniel Ferrante, Ph.D. Kelly Traverso Ryan Hoffmeister Devang Lakhani Rajinder Sobti Doug McKinnell Seb Burnett Neil Lesser Theresa Mahoney Isabelle Zee Karntipa Pisalyaput Alok Soni Christine McLaren Subadhra Parthasarathy Devon Johnson Andras Fancsik Amanda Delfiner Seshamalini Srinivasan Dr. David Chapman Sai Sri Kishan Vemavarapu https://lnkd.in/deTSHM6t
To view or add a comment, sign in
-
"Success in Action! 🌐 Explore how MedLink Pharma Services solved a critical data challenge for a pharma client."Read the full case study at https://lnkd.in/eb-WBNPv"#CaseStudy #SuccessStories #DataSuccess #PharmaChallenge #SolvedChallenge #DataSolution #CaseStudyHighlight #PharmaWins #MedLinkCaseStudy #BusinessSuccessStory
To view or add a comment, sign in
-
The latest edition of our ‘Measuring the return from pharmaceutical innovation’ report is out and good news is that R&D Productivity is trending upwards.
I am so excited to announce the publication of our latest Biopharma R&D Productivity report from Colin Terry and Kevin Dondarski . The good news is that biopharma R&D productivity is trending upward - now at 4.1% IRR - from an all-time low of 1.2% last year. Other insights include: • R&D cost per asset remained flat while peak sales per asset declined. The overall number of late stage assets increased however (less late-stage failures), which is driving the rise in IRR • Despite significant headwinds in terms of increasing trial complexity, concentrated therapeutic area focus, and a changing regulatory environment (e.g. Inflation Reduction Act), the report highlights exciting opportunities to utilize technology – namely AI – to bend the curve of R&D productivity Please read their insightful analysis and share with your R&D colleagues! Nick Lingler Amy Cheung Kevin Sullivan Amanda Kirby Bowles Siddharth Karia Nirav Mehta Raveen Sharma Jeffrey Morgan Ernest Horany Parag Limaye Ming Shen Aditya Kudumala Melanie Stephenson Rob Brathwaite George Pushchinsky Seth Levine Dawn Anderson Mukesh Singhal Daniel Ferrante, Ph.D. Kelly Traverso Ryan Hoffmeister Devang Lakhani Rajinder Sobti Doug McKinnell Seb Burnett Neil Lesser Theresa Mahoney Isabelle Zee Karntipa Pisalyaput Alok Soni Christine McLaren Subadhra Parthasarathy Devon Johnson Andras Fancsik Amanda Delfiner Seshamalini Srinivasan Dr. David Chapman Sai Sri Kishan Vemavarapu https://lnkd.in/deTSHM6t
Measuring the return from pharmaceutical innovation 2024
www2.deloitte.com
To view or add a comment, sign in
-
📊 Pioneering Pharma Intelligence: • Engage with the profundity of unified pre-market data. • Tailor strategic triumphs through informed decisions. • Chart the course towards market success with Pi Pharma Intelligence. #PharmaIntelligence #PreMarketData #PiPharma
To view or add a comment, sign in
-
FIRESIDE CHAT! Understand the potential for individuals to make significant contributions to the pharma industry, regardless of where they start their journey. This is one of the fireside chat topic whereby leaders who have navigated the ups and downs in the complex landscape of the pharma industry share their insights. Scan the QR code to register or drop in at https://lnkd.in/gUNj4K58 #PharmaConference #PharmaInnovation #PharmaExcellence #PEXLIFTAsia2024
To view or add a comment, sign in
-
📢 Attention biopharma professionals! 📢 Stay up-to-date on the latest industry trends, challenges, and best practices with our bi-monthly newsletter. Our team of experts shares deep insights and unique perspectives that can help you drive success in your work. Don't miss out - subscribe today! https://lnkd.in/diE5XFuK #Vetter #biopharma #newsletter #bestpractices #industryinsights
To view or add a comment, sign in
-
🚀++ LIVE WEBINAR ++ Join Us for the Launch of Permea Commercial Compass! 👉 https://lnkd.in/dY34iJyi In the competitive pharmaceutical industry, staying on top of market trends and performance is crucial. Unfortunately, many commercial teams are still hampered by slow, outdated, and uninspiring data, which restricts the ability of brands to perform optimally. 𝗠𝗲𝗲𝘁 𝗣𝗲𝗿𝗺𝗲𝗮 𝗖𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹 𝗖𝗼𝗺𝗽𝗮𝘀𝘀 — your solution for 𝗶𝗻𝘀𝘁𝗮𝗻𝘁, 𝗽𝗮𝘁𝗶𝗲𝗻𝘁-𝗹𝗲𝘃𝗲𝗹 𝗽𝗿𝗲𝘀𝗰𝗿𝗶𝗽𝘁𝗶𝗼𝗻 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀 This novel tool delivers precise, data-driven insights, enabling you to tailor your brand strategy and drive significant growth. Join our webinar on 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿 𝟮𝟬 𝗮𝘁 𝟭𝟭:𝟬𝟬 𝗖𝗘𝗧, where we'll showcase how Permea Commercial Compass can transform your data analytics and decision-making processes. Discover: ✅ 𝗨𝗽-𝘁𝗼-𝗗𝗮𝘁𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀: Adapt swiftly to market dynamics with immediate data access. ✅ 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗗𝘆𝗻𝗮𝗺𝗶𝗰𝘀 & 𝗕𝗿𝗮𝗻𝗱 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀: Harness detailed insights into patient behavior to refine your marketing approaches. ✅ 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗥𝗲𝗰𝗼𝗺𝗺𝗲𝗻𝗱𝗮𝘁𝗶𝗼𝗻𝘀: Utilize our data-driven insights to optimize your go-to-market and strategic initiatives. Don’t miss the opportunity to elevate your brand’s performance in the pharmaceutical market and 𝗿𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗻𝗼𝘄 𝘄𝗶𝘁𝗵 𝘁𝗵𝗲 𝗹𝗶𝗻𝗸 𝗶𝗻 𝘁𝗵𝗲 𝗰𝗮𝗽𝘁𝗶𝗼𝗻! #CommercialCompass #DataAnalytics #MarketInsights #HealthcareInnovation
To view or add a comment, sign in
-
How does ZAIDYN™ Field Development give commercial teams data to meet the evolving pharma market’s needs? Watch our on-demand webinar to find out: https://bit.ly/4aczb3f #ZAIDYN #fieldperformance #commercialstrategy
To view or add a comment, sign in
-
How can you achieve greater productivity in #biopharma? 🔍 Join us on 21 February for this live webinar and explore new approaches for integrated continuous #biomanufacturing and the criticality of PAT🔬👩🔬 Don't miss this opportunity to learn how to maximize your biopharma process efficiency 👉 Register now for our webinar! ✔️ https://okt.to/XIk6nR
To view or add a comment, sign in
37,548 followers
Senior Director, Business Development @ KBI Biopharma | PhD, CMC Development
2wImpressive!